Rajesh C. Rao

3.2k total citations · 1 hit paper
92 papers, 1.6k citations indexed

About

Rajesh C. Rao is a scholar working on Ophthalmology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Rajesh C. Rao has authored 92 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Ophthalmology, 32 papers in Molecular Biology and 19 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Rajesh C. Rao's work include Ocular Oncology and Treatments (14 papers), Epigenetics and DNA Methylation (13 papers) and Retinal Development and Disorders (13 papers). Rajesh C. Rao is often cited by papers focused on Ocular Oncology and Treatments (14 papers), Epigenetics and DNA Methylation (13 papers) and Retinal Development and Disorders (13 papers). Rajesh C. Rao collaborates with scholars based in United States, Brazil and China. Rajesh C. Rao's co-authors include Yali Dou, Netan Choudhry, Brian J. Dlouhy, Patricia Kirby, Olatilewa O. Awe, Patrick W. Hitchon, Hakan Demirci, Mark W. Johnson, Scott A. Tomlins and Andi K. Cani and has published in prestigious journals such as New England Journal of Medicine, JAMA and Nature Communications.

In The Last Decade

Rajesh C. Rao

79 papers receiving 1.6k citations

Hit Papers

Hijacked in cancer: the K... 2015 2026 2018 2022 2015 100 200 300 400

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Rajesh C. Rao 788 455 255 226 209 92 1.6k
Shahar Frenkel 556 0.7× 960 2.1× 354 1.4× 399 1.8× 196 0.9× 78 1.6k
Gerasimos Anastassiou 443 0.6× 968 2.1× 196 0.8× 568 2.5× 159 0.8× 51 1.5k
Paolo Galluzzi 272 0.3× 561 1.2× 143 0.6× 147 0.7× 86 0.4× 110 1.5k
Lauren A. Dalvin 408 0.5× 1.4k 3.1× 357 1.4× 593 2.6× 110 0.5× 152 2.0k
D. M. Albert 512 0.6× 1.1k 2.4× 382 1.5× 331 1.5× 79 0.4× 48 1.7k
Alexandre Moulin 700 0.9× 1.6k 3.5× 705 2.8× 462 2.0× 61 0.3× 89 2.3k
James O’Sullivan 1.4k 1.8× 324 0.7× 66 0.3× 99 0.4× 124 0.6× 40 2.0k
Caroline Van den Broecke 376 0.5× 117 0.3× 215 0.8× 135 0.6× 52 0.2× 49 1.2k
H. Nida Sen 429 0.5× 760 1.7× 167 0.7× 257 1.1× 122 0.6× 40 1.3k

Countries citing papers authored by Rajesh C. Rao

Since Specialization
Citations

This map shows the geographic impact of Rajesh C. Rao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rajesh C. Rao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rajesh C. Rao more than expected).

Fields of papers citing papers by Rajesh C. Rao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rajesh C. Rao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rajesh C. Rao. The network helps show where Rajesh C. Rao may publish in the future.

Co-authorship network of co-authors of Rajesh C. Rao

This figure shows the co-authorship network connecting the top 25 collaborators of Rajesh C. Rao. A scholar is included among the top collaborators of Rajesh C. Rao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rajesh C. Rao. Rajesh C. Rao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rao, Rajesh C., Brigitte L. Arduini, Susan L. Borden, et al.. (2025). Safety and tolerability of RPESC-RPE transplantation in patients with dry age-related macular degeneration: Low-dose clinical outcomes. Cell stem cell. 32(11). 1659–1670.e4.
2.
Yang, Wentao, Mengrou Shan, Li Zhang, et al.. (2024). Quiescence enables unrestricted cell fate in naive embryonic stem cells. Nature Communications. 15(1). 1721–1721. 8 indexed citations
3.
Haliyur, Rachana, et al.. (2024). Cost Drivers of Pars Plana Vitrectomy for Retinal Detachment: Time-Driven Activity-Based Costing Analysis. Journal of VitreoRetinal Diseases. 9(1). 11–17.
4.
Rao, Rajesh C., et al.. (2023). Hyperoleon: Emulsified silicone oil in anterior chamber following repair of recurrent retinal detachments. Journal Français d Ophtalmologie. 46(3). 300–301.
5.
Pan, Warren W., et al.. (2023). The Cost of Standard and Complex Pars Plana Vitrectomy for Retinal Detachment Repair Exceeds Its Reimbursement. Ophthalmology Retina. 7(11). 948–953. 5 indexed citations
6.
Balikov, Daniel A., Kevin Hu, Bryan L. Betz, et al.. (2021). Comparative Molecular Analysis of Primary Central Nervous System Lymphomas and Matched Vitreoretinal Lymphomas by Vitreous Liquid Biopsy. International Journal of Molecular Sciences. 22(18). 9992–9992. 8 indexed citations
7.
Zhao, Peter Y., Sunjong Ji, Paula Anne Newman-Casey, et al.. (2021). Assessing patient perception of risk in ocular stem cell therapies. Stem Cell Reports. 16(10). 2415–2421. 1 indexed citations
8.
Rao, Rajesh C., et al.. (2021). Research Funding, Income, and Career Satisfaction Among Clinician-Scientists in Ophthalmology in the United States. American Journal of Ophthalmology. 227. 254–264. 5 indexed citations
9.
Li, Qiang, Fengbiao Mao, Bo Zhou, et al.. (2020). p53 Integrates Temporal WDR5 Inputs during Neuroectoderm and Mesoderm Differentiation of Mouse Embryonic Stem Cells. Cell Reports. 30(2). 465–480.e6. 18 indexed citations
10.
Rao, Rajesh C., May P. Chan, Chris Andrews, & Alon Kahana. (2018). Epigenetic markers in basal cell carcinoma: universal themes in oncogenesis and tumor stratification? - a short report. Cellular Oncology. 41(6). 693–698. 9 indexed citations
11.
Abalem, Maria Fernanda, Pedro Carlos Carricondo, & Rajesh C. Rao. (2017). Bullseye Retinopathy from Antiretroviral Therapy. Ophthalmology. 124(10). 1539–1539. 4 indexed citations
12.
Rao, Rajesh C., Andi K. Cani, Daniel H. Hovelson, et al.. (2016). Comprehensive Genomic Profiling of Orbital and Ocular Adnexal Lymphomas Identifies Frequent Alterations in MYD88 and Chromatin Modifiers: New Routes to Targeted Therapies. Investigative Ophthalmology & Visual Science. 57(12). 4089–4089. 2 indexed citations
13.
Rao, Rajesh C., May P. Chan, Chris Andrews, & Alon Kahana. (2016). EZH2, Proliferation Rate, and Aggressive Tumor Subtypes in Cutaneous Basal Cell Carcinoma. JAMA Oncology. 2(7). 962–962. 14 indexed citations
14.
Zhou, Bo, Jingya Wang, Jie Xiong, et al.. (2016). PRDM16 Suppresses MLL1r Leukemia via Intrinsic Histone Methyltransferase Activity. Molecular Cell. 62(2). 222–236. 45 indexed citations
15.
Zhang, Hui, Srimonta Gayen, Jie Xiong, et al.. (2016). MLL1 Inhibition Reprograms Epiblast Stem Cells to Naive Pluripotency. Cell stem cell. 18(4). 481–494. 49 indexed citations
16.
Walters, Laura, Qiang Li, Dafydd G. Thomas, et al.. (2015). Characterization and pharmacologic targeting of EZH2, a fetal retinal protein and epigenetic regulator, in human retinoblastoma. Laboratory Investigation. 95(11). 1278–1290. 29 indexed citations
17.
Choudhry, Netan & Rajesh C. Rao. (2015). ENHANCED DEPTH IMAGING FEATURES OF A CHOROIDAL MACROVESSEL. Retinal Cases & Brief Reports. 10(1). 18–21. 11 indexed citations
18.
Badiyan, Shahed N., Rajesh C. Rao, Anthony J. Apicelli, et al.. (2014). Outcomes of Iodine-125 Plaque Brachytherapy for Uveal Melanoma With Intraoperative Ultrasonography and Supplemental Transpupillary Thermotherapy. International Journal of Radiation Oncology*Biology*Physics. 88(4). 801–805. 43 indexed citations
19.
Rao, Rajesh C. & Dong Feng Chen. (2011). Nanomedicine and Optic Nerve Regeneration—Implications for Ophthalmology. 4(1). 108–108. 3 indexed citations
20.
Rao, Rajesh C., James Varani, & H. Kaz Soong. (1992). FGF Promotes Corneal Stromal Fibroblast Motility. Journal of Ocular Pharmacology and Therapeutics. 8(1). 77–81. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026